Cision PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION
News provided byHalper Sadeh LLP
Jul 26, 2022, 4:42 PM ET
NEW YORK, July 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
1Life Healthcare, Inc. (NASDAQ: ONEM)'s sale to Amazon.com, Inc. for $18.00 per share in cash. If you are a 1Life shareholder, click here to learn more about your rights and options.
Epizyme, Inc. (NASDAQ: EPZM)'s sale to Ipsen. If you are an Epizyme shareholder, click here to learn more about your rights and options.
Lionheart III Corp (NASDAQ: LION)'s merger with Security Matters Limited. If you are a Lionheart shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email email@example.com or firstname.lastname@example.org.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-onem-epzm-lion-301593643.html
SOURCE Halper Sadeh LLP